These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 3433248

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Low affinity heparin is an antithrombotic agent.
    Gray E, Cesmeli S, Lormeau JC, Davies AB, Lane DA.
    Thromb Haemost; 1994 Feb; 71(2):203-7. PubMed ID: 8191399
    [Abstract] [Full Text] [Related]

  • 3. The relative antithrombotic effectiveness of heparin, a low molecular weight heparin, and a pentasaccharide fragment in an animal model.
    Thomas DP, Merton RE, Gray E, Barrowcliffe TW.
    Thromb Haemost; 1989 Apr 25; 61(2):204-7. PubMed ID: 2546282
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Relative efficacy of heparin and related glycosaminoglycans as antithrombotic drugs.
    Thomas DP, Merton RE, Barrowcliffe TW.
    Ann N Y Acad Sci; 1989 Apr 25; 556():313-22. PubMed ID: 2735662
    [Abstract] [Full Text] [Related]

  • 7. Antithrombotic properties of dermatan sulphate (MF 701) in haemodialysis for chronic renal failure.
    Ryan KE, Lane DA, Flynn A, Ireland H, Boisclair M, Shepperd J, Curtis JR.
    Thromb Haemost; 1992 Nov 10; 68(5):563-9. PubMed ID: 1455403
    [Abstract] [Full Text] [Related]

  • 8. Effects of sulfated polysaccharides on inhibition of thrombus formation initiated by different stimuli.
    Van Ryn-McKenna J, Gray E, Weber E, Ofosu FA, Buchanan MR.
    Thromb Haemost; 1989 Feb 28; 61(1):7-9. PubMed ID: 2473537
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Dermatan sulfate and the prevention of experimental venous thrombosis].
    Desnoyers P, Bara L, Samama M.
    Pathol Biol (Paris); 1989 Jun 28; 37(6):759-67. PubMed ID: 2674877
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antithrombotic properties of dermatan sulphate in a rat venous thrombosis model.
    Maggi A, Abbadini M, Pagella PG, Borowska A, Pangrazzi J, Donati MB.
    Haemostasis; 1987 Jun 28; 17(6):329-35. PubMed ID: 3428718
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antithrombotic activity and its relationship to in vitro anticoagulant effects.
    Gray E, Padilla A, Barrowcliffe TW.
    Haemostasis; 1993 Mar 28; 23 Suppl 1():99-102. PubMed ID: 8388358
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effects of dermatan sulfate at submicrogram/ml concentrations on in vitro thrombin generation.
    Delorme MA, Tam AS, Xu L.
    Thromb Haemost; 1996 May 28; 75(5):747-51. PubMed ID: 8725717
    [Abstract] [Full Text] [Related]

  • 20. High and low affinity heparin compared with unfractionated heparin as antithrombotic drugs.
    Merton RE, Thomas DP, Havercroft SJ, Barrowcliffe TW, Lindahl U.
    Thromb Haemost; 1984 Apr 30; 51(2):254-6. PubMed ID: 6740557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.